Focus: GT Metabolic Solutions is a legacy medical device and diagnostic company founded in 1892, specializing in magnetic compression anastomosis technology and metabolic disease solutions. The company operates as a public-stage biotech with a focus on innovative surgical and minimally invasive approaches.
Profile data last refreshed 13h ago · AI intelligence enriched 1mo ago
No open roles listed right now. Follow GT Metabolic Solutions to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Diagnostic product facing loss of exclusivity, representing legacy revenue under pressure.
Help build intelligence for GT Metabolic Solutions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from GT Metabolic Solutions's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Second H. pylori diagnostic also approaching LOE, compounding revenue headwinds in core diagnostic segment.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo